Bristol-Myers Squibb board has given acting chief financial officer Charles Bancroft the job officially, effective on Thursday, the drugmaker said.
Bancroft has been serving as acting CFO since Jan 1. He will report to Lamberto Andreotti, the company's chief operating officer who is set to become chief executive officer next month. Bancroft, who joined Bristol in 1984, replaced Jean-Marc Huet, who left Bristol for consumer goods group Unilever .
Oxea is returning to its old name and its roots.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
